We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFU icon
5351
InfuSystem Holdings
INFU
$184M
$78K ﹤0.01%
6,721
+5,212
+345% +$59.9K
LARK icon
5352
Landmark Bancorp
LARK
$191M
$78K ﹤0.01%
4,228
+2,829
+202% +$49.4K
TGB
5353
Trekor Metals
TGB
$2.48B
$78K ﹤0.01%
157,289
-6,845
-4% -$2.61K
AXU
5354
DELISTED
Alexco Resource Corp
AXU
$78K ﹤0.01%
34,767
-227,730
-87% -$421K
LTBR icon
5355
Lightbridge
LTBR
$271M
$77K ﹤0.01%
17,076
MCBS icon
5356
MetroCity Bankshares
MCBS
$1.01B
$77K ﹤0.01%
5,348
+4,120
+336% +$46.7K
MNOV icon
5357
MediciNova
MNOV
$65.5M
$77K ﹤0.01%
14,122
-214,302
-94% -$1.14M
ORGO icon
5358
Organogenesis Holdings
ORGO
$305M
$77K ﹤0.01%
19,990
+1,529
+8% +$5.51K
CRC
5359
DELISTED
California Resources Corporation
CRC
$77K ﹤0.01%
63,080
-14,952
-19% -$25.3K
NATR icon
5360
Nature's Sunshine
NATR
$354M
$76K ﹤0.01%
8,427
+6,787
+414% +$59K
VCTR icon
5361
Victory Capital Holdings
VCTR
$6.19B
$76K ﹤0.01%
4,423
-510
-10% -$8K
ASHS icon
5362
Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF
ASHS
$32.7M
$75K ﹤0.01%
2,493
+1,395
+127% +$38.8K
KALV
5363
DELISTED
KalVista Pharmaceuticals
KALV
$75K ﹤0.01%
6,179
-13,613
-69% -$145K
RRBI icon
5364
Red River Bancshares
RRBI
$662M
$75K ﹤0.01%
1,716
+1,151
+204% +$44.9K
SCOR icon
5365
Comscore
SCOR
$106M
$75K ﹤0.01%
1,213
+812
+202% +$48.7K
SDEM icon
5366
Global X MSCI SuperDividend Emerging Markets ETF
SDEM
$44.9M
$75K ﹤0.01%
2,488
VQT
5367
DELISTED
iPath S&P VEQTOR ETN
VQT
$75K ﹤0.01%
412
EGAN icon
5368
eGain
EGAN
$187M
$74K ﹤0.01%
6,647
-8,463
-56% -$77K
HURC icon
5369
Hurco Companies Inc
HURC
$135M
$74K ﹤0.01%
2,645
+1,491
+129% +$43.7K
RDNW
5370
RideNow Group
RDNW
$238M
$74K ﹤0.01%
7,579
+1,930
+34% +$15.4K
ZN
5371
DELISTED
Zion Oil & Gas, Inc.
ZN
$74K ﹤0.01%
249,171
+14,270
+6% +$3.86K
IGIC icon
5372
International General Insurance
IGIC
$1.19B
$73K ﹤0.01%
+10,555
New +$68.3K
LCTX icon
5373
Lineage Cell Therapeutics
LCTX
$269M
$73K ﹤0.01%
84,546
+26,198
+45% +$23.1K
LXP.PRC icon
5374
LXP Industrial Trust 6.5% Series C Preferred Stock
LXP.PRC
$94.1M
$73K ﹤0.01%
1,362
-150
-10% -$7.53K
PCSB
5375
DELISTED
PCSB Financial Corporation
PCSB
$73K ﹤0.01%
5,781
+3,482
+151% +$45.4K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.